logo BDSP

Base documentaire

  1. An economic evaluation of short-term inpatient rehabilitation for children with severe asthma.

    Article - En anglais


    The cost of asthma care in the United States in 1990 has been estimated to be 6.2 billion dollars.

    The greatest proportion is due to hospital care.


    We report changes in estimated medical charges of 59 children with severe asthma I year before inpatient rehabilitation and over a 4-year follow-up period.


    Asthma resource use (e.g., hospital, physician, medication) was identified before and after inpatient rehabilitation.

    Estimated charges were assigned.

    This was done retrospectively for the 1-year period before rehabilitation, prospectively during rehabilitation, and over a 4-year follow-up period.

    Patients served as their own controls

    There was no control group.


    When median asthma resource use I year before rehabilitation was compared with that during the first, second, third, and fourth years of follow-up, there was a reduction in median hospitalization and median emergency care.

    Compared with mean total medical charges the year before rehabilitation, reductions in mean total medical charges were 56.7% at the completion of the first year (excluding charges for rehabilitation), 70.5% at second year, 74.6% at third year, and 77.5% at fourth year.

    Over the 4-year postrehabilitation period, the discounted cumulative net savings was $29,605.

    The discounted cumulative net savings surpassed the mean rehabilitation charge during the early months of the fourth year of the postrehabilitation period. (...)

    Mots-clés Pascal : Asthme, Réhabilitation, Psychothérapie familiale, Corticostéroïde, Antiinflammatoire, Chimiothérapie, Traitement, Inhalation, Observance médicamenteuse, Analyse coût, Economie santé, Hôpital, Enfant, Homme, Appareil respiratoire pathologie, Bronchopneumopathie obstructive

    Mots-clés Pascal anglais : Asthma, Rehabilitation, Family psychotherapy, Corticosteroid, Antiinflammatory agent, Chemotherapy, Treatment, Inhalation, Drug compliance, Cost analysis, Health economy, Hospital, Child, Human, Respiratory disease, Obstructive pulmonary disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 96-0414305

    Code Inist : 002B30A04B. Création : 10/04/1997.